Welcome to our dedicated page for Mccormick & Co SEC filings (Ticker: MKC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
McCormick & Company, Incorporated filings document the regulatory disclosures of a Maryland operating company with NYSE-listed non-voting common stock under the symbol MKC. Recent 8-K reports cover operating and financial results, material definitive agreements, capital-structure disclosures and exhibits tied to the company's flavor business.
The filing record also includes shareholder voting results from the annual meeting, board and auditor matters, advisory compensation votes, governance changes involving accounting oversight, and registered share-plan disclosures connected to the company's Investor Services Plan. These filings describe formal corporate actions, security structure and governance matters alongside McCormick's Consumer and Flavor Solutions reporting.
McCormick & Company director Anne L. Bramman received 2,598 restricted stock units on 02/06/2026. These units were granted at a price of $0 per unit and each unit represents a contingent right to receive one share of McCormick common stock.
The restricted stock units vest in full on 02/15/2027 and will be settled in an equal number of McCormick shares. Following this grant, Bramman beneficially owned 6,704.542 shares of McCormick common stock directly.
McCormick & Co. director Gary M. Rodkin received an equity grant in the form of restricted stock units. On 02/06/2026, he was awarded 2,598 Restricted Stock Units at a price of $0 per unit, each representing a contingent right to one share of McCormick common stock.
The 2,598 Restricted Stock Units vest in full on 02/15/2027 and will be settled in an equal number of McCormick shares. After this award, Rodkin directly holds 12,110 shares of McCormick common stock and 2,598 Restricted Stock Units.
McCormick & Company director reports new stock-based award. Director Margaret M V Preston reported receiving 2,598 Restricted Stock Units on February 6, 2026 at a price of $0 per unit, representing a contingent right to receive the same number of McCormick common shares.
These Restricted Stock Units vest in full on February 15, 2027 and will be settled in an equal number of McCormick shares. After this report, Preston beneficially owned 82,142.195 shares of Common Stock – Voting and 6,235.263 shares of Common Stock – Non Voting, all held directly, plus the new 2,598 Restricted Stock Units.
McCormick & Company director Thomas Terry S reported an equity award and updated holdings. On 02/06/2026, he was granted 2,598 Restricted Stock Units at a stated price of $0. Each unit represents a contingent right to receive one share of McCormick common stock.
The 2,598 Restricted Stock Units vest in full on 02/15/2027 and will be settled in an equal number of McCormick shares at that time. Following this grant, he directly holds 1,744.01 shares of McCormick voting common stock in addition to the new RSU award.
McCormick & Company director Michael Aaron Conway reported a new equity grant. On 02/06/2026 he received 2,598 Restricted Stock Units, each representing a contingent right to one share of McCormick common stock. These RSUs vest in full on 02/15/2027 and will then be settled in an equal number of McCormick shares. Following this grant, he directly holds 16,630 shares of McCormick common stock.
McCormick & Co. director Gavin Hattersley received an equity award in the form of 2,598 Restricted Stock Units on February 6, 2026. Each unit represents a contingent right to receive one share of McCormick common stock.
The Restricted Stock Units vest in full on February 15, 2027 and will be settled in an equal number of McCormick shares. After this grant, Hattersley directly holds 406 shares of voting common stock and 906 shares of non-voting common stock, in addition to the new RSU award.
McCormick & Co. director Richard A. Dierker reported an equity grant in the form of restricted stock units. On 02/06/2026 he received 2,598 Restricted Stock Units, each representing a contingent right to one share of McCormick common stock.
The Restricted Stock Units vest in full on 02/15/2027, after which they are settled in an equal number of McCormick shares. Following this grant, Dierker directly holds 2,598 Restricted Stock Units and 406 shares of McCormick common stock.
McCormick & Co. director Michael D. Mangan reported several equity transactions in company stock. On 02/05/2026 he exercised options to acquire 5,000 shares of Common Stock - Voting at $49.96 per share, increasing his directly held voting stake to 43,029 shares, plus 4,234 shares of Common Stock - Non Voting.
That same day, he disposed of 3,751 voting shares at $66.58. Separately, on 02/06/2026 he received a grant of 2,598 Restricted Stock Units, each representing a right to one share of McCormick common stock, which vest in full on 02/15/2027 and will be settled in an equal number of shares.
McCormick & Co. director Jacques Tapiero reported several equity transactions. On 02/05/2026 he exercised options for 5,000 shares of Common Stock - Voting at $49.96 per share and sold 5,000 shares at $67.09, leaving 31,596.054 voting shares held directly. He also holds 2,620 Common Stock - Non Voting shares.
On 02/06/2026 he received 2,598 Restricted Stock Units, each representing one share of Common Stock - Voting, which vest in full on 02/15/2027. In addition, he indirectly holds 2,206.082 phantom stock units under a Non-Qualified Retirement Savings Plan, each linked to one share of voting common stock.
McCormick & Company, Incorporated issued and sold $500 million aggregate principal amount of 4.150% Notes due 2029 under an underwriting agreement with BofA Securities, Truist Securities and Wells Fargo Securities.
The notes are unsecured senior debt under an existing indenture and pay 4.150% interest semi-annually each February 15 and August 15, beginning August 15, 2026. McCormick plans to use the net proceeds to redeem a portion of its outstanding $500 million 0.90% Notes due 2026, including related interest, fees and expenses. The notes may be redeemed before maturity at specified prices and must be repurchased at 101% of principal plus accrued interest if a defined change of control occurs. The indenture also limits certain liens, sale-leaseback transactions and major corporate reorganizations and includes customary events of default.